查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595388

血浆治疗市场：按类型、按应用划分 - 2025-2030 年全球预测

Plasma Therapy Market by Type (Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF)), Application (Dental, Dermatology, Nerve Injury) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血浆治疗市值为3.5973亿美元，预计2024年将达到3.8919亿美元，复合年增长率为11.73%，到2030年将达到7.8195亿美元。

血浆治疗，特别是在恢復期血浆治疗的情况下，涉及输入从感染疾病中康復的个体的血浆。血浆治疗的范围也扩展到使用血浆中存在的中和抗体来治疗病毒感染疾病。当发生没有特定治疗方法或疫苗的疾病时，这一点尤其重要。应用包括恢復期、免疫球蛋白治疗和治疗性血浆置换，最终用途主要在医院、学术研究机构和治疗中心。该市场的推动因素是自体免疫疾病的盛行率不断上升，以及对改善针对危及生命的病毒感染疾病（如 COVID-19）的治疗方法的日益增长的需求。此外，人口老化将导致血浆捐赠者持续涌入，推动市场扩张。研究和技术的进步带来了新的市场机会，并推动血浆采集和储存技术的创新，以提高功效和安全性。然而，市场面临重大挑战，包括监管不确定性、输血感染疾病的风险以及平衡血浆供需方面的后勤障碍。治疗的标准化也是一个主要障碍，它可能导致治疗结果的改变。该市场开拓包括开发用于高效血浆分离和处理的自动化设备。研究还可以针对基因工程来提高血浆的有效性。学术、临床和工业相关人员之间的合作可以加速新协议的开发和新血浆用例的识别。这些努力将促进市场竞争并扩大治疗选择。因此，市场动态是动态的，潜在的成长受到后勤和监管复杂性的限制。对创新和策略伙伴关係的关注可以为克服这些障碍并开拓新的成长机会指明道路。

主要市场统计
基准年[2023] 3.5973亿美元
预测年份 [2024] 3.8919 亿美元
预测年份 [2030] 78195万美元
复合年增长率（%） 11.73%

市场动态：快速发展的血浆治疗市场的关键市场洞察

供需的动态交互作用正在改变血浆治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球感染疾病与慢性病流行
    • 倾向于疾病的早期诊断和治疗
    • 检验血浆疗法有效性的临床试验增加
  • 市场限制因素
    • 血浆疗法治疗成本上升
  • 市场机会
    • 富血小板血浆治疗的进展
    • 血浆疗法在皮肤科的新用途
  • 市场挑战
    • 与血浆治疗相关的副作用

波特五力：驾驭血浆治疗市场的策略工具

波特的五力框架是了解血浆治疗市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解血浆治疗市场的外部影响

外部宏观环境因素在塑造血浆治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解血浆治疗市场的竞争格局

对血浆治疗市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质血浆治疗市场供应商绩效评估

FPNV定位矩阵是评估血浆治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划血浆治疗市场的成功之路

血浆治疗市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地感染疾病和慢性病的流行情况
      • 疾病的早​​期诊断和治疗趋势
      • 增加临床试验来测试血浆疗法的有效性
    • 抑制因素
      • 血浆疗法治疗费用高
    • 机会
      • 血小板富集血浆疗法的进展
      • 血浆疗法在皮肤科的新用途
    • 任务
      • 与血浆治疗相关的不良反应
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 血浆治疗市场：依类型

  • PRP含有大量白血球
  • 含白血球纤维蛋白 (L-PRF)
  • 纯血小板纤维蛋白 (PRF)
  • 纯PRP

第七章 血浆治疗市场：依应用分类

  • 牙科
  • 皮肤科
  • 神经损伤
  • 整形外科

第八章美洲血浆治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太血浆治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲血浆治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abeona Therapeutics Inc.
  • ADMA Biologics, Inc.
  • Arthrex, Inc.
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Exactech Inc.
  • GC Pharma
  • Global Stem Cells Group, Inc.
  • Green Cross Corporation
  • Grifols, SA
  • Hualan Biological Engineering Inc.
  • Interstate Blood Bank, Inc.
  • Japan Blood Products Organization
  • Johnson & Johnson Services, Inc.
  • Kedrion SpA
  • LFB SA
  • Octapharma AG
  • Regen Lab SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • Stryker Corporation
  • Takeda Pharmaceutical Company Limited
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc
Product Code: MRR-DD0700E81E9A

The Plasma Therapy Market was valued at USD 359.73 million in 2023, expected to reach USD 389.19 million in 2024, and is projected to grow at a CAGR of 11.73%, to USD 781.95 million by 2030.

Plasma therapy, especially in the context of convalescent plasma therapy, involves the transfusion of plasma from individuals who have recovered from infections. The scope of plasma therapy extends to its application in treating viral infections by utilizing neutralizing antibodies present in the plasma. It is a crucial therapeutic tool, particularly for disease outbreaks where specific treatments or vaccines are unavailable. The application spans convalescent plasma therapy, immunoglobulin therapy, and therapeutic plasma exchange, with end-use mainly in hospitals, academic research institutes, and therapeutic centers. The market is driven by rising incidences of autoimmune diseases and the increased necessity for improved treatments for life-threatening viral infections like COVID-19. Additionally, the aging population presents a continuous influx of plasma donors, thereby facilitating market expansion. Advancements in research and technology promise new market opportunities, inviting innovation in plasma collection and storage techniques to enhance efficacy and safety. However, the market faces substantial challenges such as regulatory uncertainties, risks of transfusion-transmitted infections, and logistical hurdles in plasma supply and demand balance. A significant barrier remains the standardization of therapies, which can lead to varied treatment outcomes. Innovating within this market could involve developing automated devices for efficient plasma separation and processing. Research could also target genetic engineering to enhance plasma efficacy. Collaborations across academic, clinical, and industry stakeholders could accelerate the development of new protocols and the identification of novel plasma-use-cases. These efforts will drive market competitiveness and broaden therapeutic options. The plasma therapy market is thus dynamic, with potential growth tempered by logistical and regulatory complexities. Emphasizing innovation and strategic partnerships can provide a pathway to overcoming these barriers and exploiting new growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 359.73 million
Estimated Year [2024] USD 389.19 million
Forecast Year [2030] USD 781.95 million
CAGR (%) 11.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Plasma Therapy Market

The Plasma Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of infectious and chronic diseases worldwide
    • Inclination towards early diagnosis and treatment of diseases
    • Increase in number of clinical trials to test efficacy of plasma therapy
  • Market Restraints
    • High cost of plasma therapy treatment
  • Market Opportunities
    • Advancements in platelet-rich plasma therapy
    • Emerging use of plasma therapy in dermatology
  • Market Challenges
    • Adverse effects associated with the plasma therapy

Porter's Five Forces: A Strategic Tool for Navigating the Plasma Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Plasma Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Plasma Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Plasma Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Plasma Therapy Market

A detailed market share analysis in the Plasma Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Plasma Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Plasma Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Plasma Therapy Market

A strategic analysis of the Plasma Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Plasma Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., ADMA Biologics, Inc., Arthrex, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Exactech Inc., GC Pharma, Global Stem Cells Group, Inc., Green Cross Corporation, Grifols, S.A., Hualan Biological Engineering Inc., Interstate Blood Bank, Inc., Japan Blood Products Organization, Johnson & Johnson Services, Inc., Kedrion S.p.A., LFB S.A., Octapharma AG, Regen Lab SA, Shanghai RAAS Blood Products Co., Ltd., Stryker Corporation, Takeda Pharmaceutical Company Limited, Terumo Corporation, and Zimmer Biomet Holdings, Inc.

Market Segmentation & Coverage

This research report categorizes the Plasma Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF), and Pure PRP.
  • Based on Application, market is studied across Dental, Dermatology, Nerve Injury, and Orthopedics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Inclination towards early diagnosis and treatment of diseases
      • 5.1.1.3. Increase in number of clinical trials to test efficacy of plasma therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of plasma therapy treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in platelet-rich plasma therapy
      • 5.1.3.2. Emerging use of plasma therapy in dermatology
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with the plasma therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Plasma Therapy Market, by Type

  • 6.1. Introduction
  • 6.2. Leucocyte-rich PRP
  • 6.3. Leukocyte-rich Fibrin (L-PRF)
  • 6.4. Pure Platelet-rich Fibrin (PRF)
  • 6.5. Pure PRP

7. Plasma Therapy Market, by Application

  • 7.1. Introduction
  • 7.2. Dental
  • 7.3. Dermatology
  • 7.4. Nerve Injury
  • 7.5. Orthopedics

8. Americas Plasma Therapy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Plasma Therapy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Plasma Therapy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abeona Therapeutics Inc.
  • 2. ADMA Biologics, Inc.
  • 3. Arthrex, Inc.
  • 4. Bio Products Laboratory Ltd.
  • 5. Biotest AG
  • 6. China Biologic Products, Inc.
  • 7. CSL Limited
  • 8. Emergent BioSolutions Inc.
  • 9. Exactech Inc.
  • 10. GC Pharma
  • 11. Global Stem Cells Group, Inc.
  • 12. Green Cross Corporation
  • 13. Grifols, S.A.
  • 14. Hualan Biological Engineering Inc.
  • 15. Interstate Blood Bank, Inc.
  • 16. Japan Blood Products Organization
  • 17. Johnson & Johnson Services, Inc.
  • 18. Kedrion S.p.A.
  • 19. LFB S.A.
  • 20. Octapharma AG
  • 21. Regen Lab SA
  • 22. Shanghai RAAS Blood Products Co., Ltd.
  • 23. Stryker Corporation
  • 24. Takeda Pharmaceutical Company Limited
  • 25. Terumo Corporation
  • 26. Zimmer Biomet Holdings, Inc

LIST OF FIGURES

  • FIGURE 1. PLASMA THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PLASMA THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PLASMA THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PLASMA THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLASMA THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PLASMA THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PLASMA THERAPY MARKET SIZE, BY LEUCOCYTE-RICH PRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PLASMA THERAPY MARKET SIZE, BY LEUKOCYTE-RICH FIBRIN (L-PRF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PLASMA THERAPY MARKET SIZE, BY PURE PLATELET-RICH FIBRIN (PRF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PLASMA THERAPY MARKET SIZE, BY PURE PRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PLASMA THERAPY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PLASMA THERAPY MARKET SIZE, BY NERVE INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2023